Fine-needle aspiration cytology samples: a good source of material for evaluating biomarkers in breast cancer
- 21 April 2014
- journal article
- other
- Published by Wiley in Histopathology
- Vol. 66 (2), 314-315
- https://doi.org/10.1111/his.12439
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Low concordance of biomarkers in histopathological and cytological material from breast cancerHistopathology, 2013
- Latest biopsy approach for suspected metastases in patients with breast cancerNature Reviews Clinical Oncology, 2013
- Cancer Care Ontario Guideline Recommendations for Hormone Receptor Testing in Breast CancerClinical Oncology, 2012
- Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2012
- Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast CancerJournal of Clinical Oncology, 2012
- Role of ancillary studies in fine‐needle aspiration from selected tumorsCancer Cytopathology, 2011
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working GroupJNCI Journal of the National Cancer Institute, 2011
- Standardization of Estrogen Receptor Measurement in Breast Cancer Suggests False-Negative Results Are a Function of Threshold Intensity Rather Than Percentage of Positive CellsJournal of Clinical Oncology, 2011
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI Journal of the National Cancer Institute, 2009
- Estimation of hormone receptor status in fine‐needle aspirates and paraffin‐embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2Diagnostic Cytopathology, 2003